CLOPIXOL

This brand name is authorized in Australia, Brazil, Canada, Cyprus, Germany, Spain, France, Hong Kong, Ireland, Israel, Malta, Mexico, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug CLOPIXOL contains one active pharmaceutical ingredient (API):

1 Zuclopenthixol UNII 47ISU063SG - ZUCLOPENTHIXOL

Zuclopenthixol is a potent neuroleptic of the thioxanthene series with a piperazine side-chain. The antipsychotic effect of neuroleptics is related to their dopamine receptor blocking effect. Read about Zuclopenthixol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CLOPIXOL Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
CLOPIXOL ACUPHASE Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
CLOPIXOL Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AF05	Zuclopenthixol	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives
Discover more medicines within N05AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8097E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 524200201114412, 524200202110410, 524200203151412, 524200204156418
Country: CA	Health Products and Food Branch	Identifier(s): 02230402, 02230403, 02230405, 02230406
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01125028, 01177930, 02522056, 02752543, 02752566, 03569634, 06585384, 06729469, 09102802, 09321792, 10930740, 13713552, 14136051, 14236605, 15266318, 17562908
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60871, 60872, 60873, 60874, 60875
Country: FR	Base de données publique des médicaments	Identifier(s): 60209937, 61323662, 62788550, 63744998, 68072846, 69974746
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147150, 147160, 198691, 24633, 24634, 24635, 27619, 27629, 377428, 399365, 41302
Country: HK	Department of Health Drug Office	Identifier(s): 19861, 22761
Country: IE	Health Products Regulatory Authority	Identifier(s): 17841, 17914, 18139
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2426, 623, 624, 626, 627, 628, 629, 630, 6787, 6788, 6789, 6790
Country: MT	Medicines Authority	Identifier(s): AA565/28903, MA1323/00101
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 414M96, 415M96, 417M96
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5434, 5435, 5436
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100015033, 100015040, 100015056, 100248091
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W10638002, W12431001, W12437002, W12437003, W12439002, W12439003, W13182005
Country: SG	Health Sciences Authority	Identifier(s): 01365P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699795090505, 8699795091335, 8699795091342, 8699795590012, 8699795750201, 8699795750225
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/2.6.5/52, T/2.6.5/180, T/2.6.5/181, W/2.6.5/27